Ticagrelor
- Product NDC
- 0480-2695
- 11-digit product format
- 004802695
- Labeler code
- 0480
- Product ID
- 0480-2695_a4b5ee2e-a273-4371-9477-8f84c83cc317
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ticagrelor
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA208390
- Marketing category
- ANDA
- Marketing start
- 2025-05-01
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| GLH0314RVC | TICAGRELOR | 274693-27-5 | TICAGRELOR |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0480-2695-06 | 00480269506 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-2695-06) | 2025-05-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Ticagrelor | Teva Pharmaceuticals, Inc. | 2024-12-20 | HUMAN PRESCRIPTION DRUG LABEL | 2 |